These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 29143673)

  • 1. The HepTestContest: a global innovation contest to identify approaches to hepatitis B and C testing.
    Tucker JD; Meyers K; Best J; Kaplan K; Pendse R; Fenton KA; Andrieux-Meyer I; Figueroa C; Goicochea P; Gore C; Ishizaki A; Khwairakpam G; Miller V; Mozalevskis A; Ninburg M; Ocama P; Peeling R; Walsh N; Colombo MG; Easterbrook P
    BMC Infect Dis; 2017 Nov; 17(Suppl 1):701. PubMed ID: 29143673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survey of programmatic experiences and challenges in delivery of hepatitis B and C testing in low- and middle-income countries.
    Ishizaki A; Bouscaillou J; Luhmann N; Liu S; Chua R; Walsh N; Hess S; Ivanova E; Roberts T; Easterbrook P
    BMC Infect Dis; 2017 Nov; 17(Suppl 1):696. PubMed ID: 29143609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Values, preferences and current hepatitis B and C testing practices in low- and middle-income countries: results of a survey of end users and implementers.
    Reipold EI; Trianni A; Krakower D; Ongarello S; Roberts T; Easterbrook P; Denkinger C
    BMC Infect Dis; 2017 Nov; 17(Suppl 1):702. PubMed ID: 29143612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crowdsourcing to increase hepatitis B and C testing and reduce hepatitis stigma among medical students in Bangladesh.
    Ali M; Tucker JD; Kpokiri EE; Wu D; Rahman MA; Mia T; Chowdhury MSA; Ahmed F; Hakim HAN; Paiker ZM; Nuha NJ
    J Viral Hepat; 2024 Jul; 31(7):404-408. PubMed ID: 38679925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incorporating HIV/hepatitis B virus/hepatitis C virus combined testing into routine blood tests in nine UK Emergency Departments: the "Going Viral" campaign.
    Orkin C; Flanagan S; Wallis E; Ireland G; Dhairyawan R; Fox J; Nandwani R; O'Connell R; Lascar M; Bulman J; Reeves I; Palfreeman A; Foster GR; Ahmad K; Anderson J; Tong CY; Lattimore S
    HIV Med; 2016 Mar; 17(3):222-30. PubMed ID: 26919291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are the testing needs of key European populations affected by hepatitis B and hepatitis C being addressed? A scoping review of testing studies in Europe.
    Lazarus JV; Sperle I; Spina A; Rockstroh JK
    Croat Med J; 2016 Oct; 57(5):442-456. PubMed ID: 27815935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A crowdsourced intervention to promote hepatitis B and C testing among men who have sex with men in China: study protocol for a nationwide online randomized controlled trial.
    Fitzpatrick T; Zhou K; Cheng Y; Chan PL; Cui F; Tang W; Mollan KR; Guo W; Tucker JD
    BMC Infect Dis; 2018 Sep; 18(1):489. PubMed ID: 30268114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for latent TB, HIV, and hepatitis B/C in new migrants in a high prevalence area of London, UK: a cross-sectional study.
    Hargreaves S; Seedat F; Car J; Escombe R; Hasan S; Eliahoo J; Friedland JS
    BMC Infect Dis; 2014 Dec; 14():657. PubMed ID: 25466442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Innovation contests to promote sexual health in China: a qualitative evaluation.
    Zhang W; Schaffer D; Tso LS; Tang S; Tang W; Huang S; Yang B; Tucker JD
    BMC Public Health; 2017 Jan; 17(1):78. PubMed ID: 28088211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One or two serological assay testing strategy for diagnosis of HBV and HCV infection? The use of predictive modelling.
    Parry JV; Easterbrook P; Sands AR
    BMC Infect Dis; 2017 Nov; 17(Suppl 1):705. PubMed ID: 29143611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The civil society monitoring of hepatitis C response related to the WHO 2030 elimination goals in 35 European countries.
    Maticic M; Pirnat Z; Leicht A; Zimmermann R; Windelinck T; Jauffret-Roustide M; Duffell E; Tammi T; Schatz E
    Harm Reduct J; 2020 Nov; 17(1):89. PubMed ID: 33213481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2014 French guidelines for hepatitis B and C screening: a combined targeted and mass testing strategy of chronic viruses namely HBV, HCV and HIV.
    Bottero J; Brouard C; Roudot-Thoraval F; Deuffic-Burban S; Hofliger P; Abergel A; Volant J; Dhumeaux D; Yazdanpanah Y;
    Liver Int; 2016 Oct; 36(10):1442-9. PubMed ID: 27043826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-Effectiveness of Testing and Treatment for Hepatitis B Virus and Hepatitis C Virus Infections: An Analysis by Scenarios, Regions, and Income.
    Tordrup D; Hutin Y; Stenberg K; Lauer JA; Hutton DW; Toy M; Scott N; Chhatwal J; Ball A
    Value Health; 2020 Dec; 23(12):1552-1560. PubMed ID: 33248510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative evaluation of an innovation contest to enhance a sexual health campaign in China.
    Zhang Y; Tang S; Li K; Tso LS; Bayus BL; Glidden D; Yang B; Zheng H; Wei C; Tucker J; Tang W
    BMC Infect Dis; 2019 Feb; 19(1):112. PubMed ID: 30717678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C elimination among people who inject drugs: Challenges and recommendations for action within a health systems framework.
    Day E; Hellard M; Treloar C; Bruneau J; Martin NK; Øvrehus A; Dalgard O; Lloyd A; Dillon J; Hickman M; Byrne J; Litwin A; Maticic M; Bruggmann P; Midgard H; Norton B; Trooskin S; Lazarus JV; Grebely J;
    Liver Int; 2019 Jan; 39(1):20-30. PubMed ID: 30157316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modelling the elimination of hepatitis C as a public health threat in Iceland: A goal attainable by 2020.
    Scott N; Ólafsson S; Gottfreðsson M; Tyrfingsson T; Rúnarsdóttir V; Hansdottir I; Hernandez UB; Sigmundsdóttir G; Hellard M
    J Hepatol; 2018 May; 68(5):932-939. PubMed ID: 29274408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Economic Evaluation of the Cost-Effectiveness of Opt-Out Hepatitis B and Hepatitis C Testing in an Emergency Department Setting in the United Kingdom.
    Williams J; Vickerman P; Douthwaite S; Nebbia G; Hunter L; Wong T; Ruf M; Miners A
    Value Health; 2020 Aug; 23(8):1003-1011. PubMed ID: 32828211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Values and preferences for hepatitis C self-testing among people who inject drugs in Kyrgyzstan.
    Martínez-Pérez GZ; Nikitin DS; Bessonova A; Fajardo E; Bessonov S; Shilton S
    BMC Infect Dis; 2021 Jun; 21(1):609. PubMed ID: 34171990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.